Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
43%
ALSO IN BBH
BBH
27
HOLDINGS
50%
ALSO IN PBE
SECTOR DRIFT (PBE minus BBH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 4.9% | 9.1% | 4.9% |
|
AMGEN INC | 4.8% | 14.7% | 4.8% |
|
REGENERON PHARMACEUTICALS | 4.8% | 7.8% | 4.8% |
|
GILEAD SCIENCES INC | 4.6% | 13.9% | 4.6% |
|
BIOGEN IDEC INC | 5.5% | 3.3% | 3.3% |
PBE Overweight Relative to BBH
|
ROYALTY PHARMA PLC CLASS A | 4.7% |
|
IONIS PHARMACEUTICALS, INC. | 4.2% |
|
PTC THERAPEUTICS INC | 3.4% |
|
SAREPTA THERAPEUTICS INC | 3.2% |
|
VERACYTE INC | 3.2% |
|
INCYTE CORP | 2.8% |
|
EXELIXIS INC | 2.7% |
|
CATALYST PHARMACEUTICAL PART | 2.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.7% |
|
DYNAVAX TECHNOLOGIES CORP | 2.5% |
PBE Underweight Relative to BBH
|
AMGEN INC | -9.9% |
|
GILEAD SCIENCES INC | -9.3% |
|
IQVIA HOLDINGS INC | -4.8% |
|
ALNYLAM PHARMACEUTICALS INC | -4.3% |
 |
ARGENX SE ADR | -4.3% |
|
NATERA INC | -4.3% |
|
VERTEX PHARMACEUTICALS INC | -4.3% |
|
INSMED INC | -4.1% |
|
BEIGENE LTD. SPONSORED ADR | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.0% |